Form 4 for AXGN Axogen, Inc.
Accepted 2024-09-04 00:00:00 ET · period of report 2024-09-01 · accession 0000805928-24-000121 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-09-04 | 2024-09-01 | AXGN | JOHNSON JOHN | Dir | M - OptEx | $0.00 | +11.9K | 29.0K | +70% | $0 |
| D | 2024-09-04 | 2024-09-01 | AXGN | JOHNSON JOHN | Dir | M - OptEx | $0.00 | -11.9K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-01 | M | A | 11,904 | $0.00 | 29,016 | D | — | — | (F1) This reflects the number of restricted stock units that vested on September 1, 2024. |
| 2 | Derivative | Restricted Stock Units | 2024-09-01 | M | D | 11,904 | $0.00 | 0 | D | — · — to — | 11,904 Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock. (F3) Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on September 1, 2024, one year anniversary of the grant date. |